Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ABILIFY vs ACALABRUTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ABILIFY vs ACALABRUTINIB: Safety Overview

Metric ABILIFY ACALABRUTINIB
Total FAERS Reports 379 9,688
Deaths Reported 39 2,239
Death Rate 10.3% 23.1%
Hospitalizations 111 2,441
Average Patient Age 43.1 yrs 73.2 yrs
% Female Patients N/A 36.8%
FDA Approval Date N/A Aug 3, 2022
Manufacturer N/A AstraZeneca Pharmaceuticals LP
Route N/A ORAL
Marketing Status N/A Prescription